-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明,無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
STOCKHOLDER ALERT: The M&A Class Action Firm Continues the Investigation of the Merger - USX, OSH, TESS, CHRA, STSA
STOCKHOLDER ALERT: The M&A Class Action Firm Continues the Investigation of the Merger - USX, OSH, TESS, CHRA, STSA
NEW YORK, April 28, 2023 /PRNewswire/ -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the "M&A Class Action Firm"), a national securities firm rated Top 50 in the 2018-2021 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is investigating:
- U.S. Xpress Enterprises, Inc. (NYSE: USX), relating to its proposed sale to Knight-Swift Transportation Holdings Inc. Under the terms of the agreement, USX shareholders are expected to receive $6.15 in cash per share they own. Click here for more information: It is free and there is no cost or obligation to you.
- Oak Street Health, Inc. (NYSE: OSH), relating to its proposed sale to CVS Health. Under the terms of the agreement, OSH shareholders are expected to receive $39.00 in cash per share they own. Click here for more information: It is free and there is no cost or obligation to you.
- TESSCO Technologies Inc. (NASDAQ: TESS), relating to its proposed sale to affiliates of Lee Equity Partners and Twin Point Capital. Under the terms of the agreement, TESS shareholders are expected to receive $9.00 in cash per share they own. Click here for more information: It is free and there is no cost or obligation to you.
- Charah Solutions, Inc. (OTC: CHRA), relating to its proposed sale to SER Capital Partners/ Under the terms of the agreement, CHRA shareholders are expected to receive $6.00 in cash per share they own. Click here for more information: It is free and there is no cost or obligation to you.
- Satsuma Pharmaceuticals, Inc. (NASDAQ: STSA), relating to its proposed sale to Shin Nippon Biomedical Laboratories, Ltd. Under the terms of the agreement, STSA Shareholders are expected to receive one non-tradeable CVR of up to $5.77 in cash plus $0.91 in cash per share they own. Click here for more information: It is free and there is no cost or obligation to you.
About Monteverde & Associates PC
We are a national class action securities and consumer litigation law firm that has recovered millions of dollars for shareholders and is committed to protecting investors and consumers from corporate wrongdoing. Monteverde & Associates lawyers have significant experience litigating Mergers & Acquisitions and Securities Class Actions, whereby they protect investors by recovering money and remedying corporate misconduct. Mr. Monteverde, who leads the firm, has been recognized by Super Lawyers as a Rising Star in Securities Litigation in 2013 and 2017-2019, an award given to less than 2.5% of attorneys in a particular field. He has also been selected by Martindale-Hubbell as a 2017-2020 Top Rated Lawyer. Our firm's recent successes include changing the law in a significant victory that lowered the standard of liability under Section 14(e) of the Exchange Act in the Ninth Circuit. Thereafter, our firm successfully preserved this victory by obtaining dismissal of a writ of certiorari as improvidently granted at the United States Supreme Court. Emulex Corp. v. Varjabedian, 139 S. Ct. 1407 (2019). Also, over the years the firm has recovered or secured over a dozen cash common funds for shareholders in mergers & acquisitions class action cases.
If you own common stock in any of the above listed companies and wish to obtain additional information and protect your investments free of charge, please visit our website or contact Juan E. Monteverde, Esq. either via e-mail at [email protected] or by telephone at (212) 971-1341.
Contact:
Juan E. Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC
The Empire State Building
350 Fifth Ave. Suite 4405
New York, NY 10118
United States of America
[email protected]
Tel: (212) 971-1341
Attorney Advertising. (C) 2023 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (). Prior results do not guarantee a similar outcome with respect to any future matter.
SOURCE Monteverde & Associates PC
NEW YORK, April 28, 2023 /PRNewswire/ -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the "M&A Class Action Firm"), a national securities firm rated Top 50 in the 2018-2021 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is investigating:
紐約, 2023年4月28日 /PRNewswire/ — 胡安·蒙特維德,集體訴訟公司Monteverde & Associates PC(“併購集體訴訟公司”)的創始人兼管理合夥人,該公司被評爲全國性證券公司 前 50 名 在 2018-2021 年 ISS 證券集體訴訟服務報告中,總部位於 帝國大廈 在 紐約市,正在調查:
-
U.S. Xpress Enterprises, Inc. (NYSE: USX), relating to its proposed sale to Knight-Swift Transportation Holdings Inc. Under the terms of the agreement, USX shareholders are expected to receive $6.15 in cash per share they own. Click here for more information: It is free and there is no cost or obligation to you.
-
Oak Street Health, Inc. (NYSE: OSH), relating to its proposed sale to CVS Health. Under the terms of the agreement, OSH shareholders are expected to receive $39.00 in cash per share they own. Click here for more information: It is free and there is no cost or obligation to you.
-
TESSCO Technologies Inc. (NASDAQ: TESS), relating to its proposed sale to affiliates of Lee Equity Partners and Twin Point Capital. Under the terms of the agreement, TESS shareholders are expected to receive $9.00 in cash per share they own. Click here for more information: It is free and there is no cost or obligation to you.
-
Charah Solutions, Inc. (OTC: CHRA), relating to its proposed sale to SER Capital Partners/ Under the terms of the agreement, CHRA shareholders are expected to receive $6.00 in cash per share they own. Click here for more information: It is free and there is no cost or obligation to you.
- Satsuma Pharmaceuticals, Inc. (NASDAQ: STSA), relating to its proposed sale to Shin Nippon Biomedical Laboratories, Ltd. Under the terms of the agreement, STSA Shareholders are expected to receive one non-tradeable CVR of up to $5.77 in cash plus $0.91 in cash per share they own. Click here for more information: It is free and there is no cost or obligation to you.
-
美國 Xpress 企業有限公司 (紐約證券交易所:USX),與其出售給奈特-斯威夫特運輸控股公司的提議有關。根據協議條款,預計美國證券交易所股東將獲得 6.15 美元 他們擁有的每股現金。 點擊這裏瞭解更多信息: 它是免費的,您無需支付任何費用或義務。
-
橡樹街健康有限公司 (紐約證券交易所:OSH),與其出售給CVS Health的提議有關。根據協議條款,預計職業安全與健康股東將獲得 39.00 美元 他們擁有的每股現金。 點擊這裏瞭解更多信息: 它是免費的,您無需支付任何費用或義務。
-
樂購科技公司 (納斯達克股票代碼:TESS),涉及其向Lee Equity Partners和Twin Point Capital的關聯公司出售根據協議條款,預計TESS股東將獲得 9.00 美元 他們擁有的每股現金。 點擊這裏瞭解更多信息: 它是免費的,您無需支付任何費用或義務。
-
Charah Solutions, Inc (場外交易時間:CHRA),與其向SER Capital Partners出售的提議有關/根據協議條款,CHRA股東預計將獲得 6.00 美元 他們擁有的每股現金。 點擊這裏瞭解更多信息: 它是免費的,您無需支付任何費用或義務。
- 薩摩製藥株式會社 (納斯達克股票代碼:STSA),與其向新日本生物醫學實驗室有限公司出售的提議有關。根據協議條款,預計STSA股東將獲得一份最多可交易的CVR 5.77 美元 現金 plus 0.91 美元 他們擁有的每股現金。 點擊這裏瞭解更多信息: 它是免費的,您無需支付任何費用或義務。
About Monteverde & Associates PC
關於 Monteverde & Ass
We are a national class action securities and consumer litigation law firm that has recovered millions of dollars for shareholders and is committed to protecting investors and consumers from corporate wrongdoing. Monteverde & Associates lawyers have significant experience litigating Mergers & Acquisitions and Securities Class Actions, whereby they protect investors by recovering money and remedying corporate misconduct. Mr. Monteverde, who leads the firm, has been recognized by Super Lawyers as a Rising Star in Securities Litigation in 2013 and 2017-2019, an award given to less than 2.5% of attorneys in a particular field. He has also been selected by Martindale-Hubbell as a 2017-2020 Top Rated Lawyer. Our firm's recent successes include changing the law in a significant victory that lowered the standard of liability under Section 14(e) of the Exchange Act in the Ninth Circuit. Thereafter, our firm successfully preserved this victory by obtaining dismissal of a writ of certiorari as improvidently granted at the United States Supreme Court. Emulex Corp. v. Varjabedian, 139 S. Ct. 1407 (2019). Also, over the years the firm has recovered or secured over a dozen cash common funds for shareholders in mergers & acquisitions class action cases.
我們是一家全國性的集體訴訟、證券和消費者訴訟律師事務所 已經收回了數百萬美元 對於股東和 是 致力於保護投資者 以及消費者因企業不當行爲而受害。Monteverde & Associates的律師在提起併購和證券集體訴訟訴訟方面擁有豐富的經驗,他們通過追回資金和糾正公司不當行爲來保護投資者。領導該事務所的蒙特維德先生在2013年和2017-2019年被《超級律師》評爲證券訴訟的後起之秀,該獎項授予特定領域的不到2.5%的律師。他還被選中 馬丁代爾-哈貝爾是2017-2020年最受好評的律師。我們公司最近的成功包括修改法律,這是一項重大勝利,降低了第九巡迴法院《交易法》第14(e)條規定的責任標準。此後,我們公司成功地維護了這一勝利,撤銷了美國最高法院臨時批准的移審令。 Emulex Corp. 訴 Varjabedian,139 S. Ct. 1407 (2019)。此外,多年來,該公司在併購集體訴訟案件中爲股東追回或擔保了十幾只現金普通基金。
If you own common stock in any of the above listed companies and wish to obtain additional information and protect your investments free of charge, please visit our website or contact Juan E. Monteverde, Esq. either via e-mail at [email protected] or by telephone at (212) 971-1341.
如果您擁有上述任何一家上市公司的普通股並希望獲得更多信息並免費保護您的投資,請訪問我們的 網站 或者聯繫 Juan E. Monteverde,Esq 要麼通過電子郵件發送 [電子郵件保護] 或者致電 (212) 971-1341。
Contact:
Juan E. Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC
The Empire State Building
350 Fifth Ave. Suite 4405
New York, NY 10118
United States of America
[email protected]
Tel: (212) 971-1341
聯繫人:
Juan E. Monteverde,Esq
MONTEVERDE & SO
帝國大廈
第五大道 350 號4405 套房
紐約,紐約 10118
美利堅合衆國
[電子郵件保護]
電話:(212) 971-1341
Attorney Advertising. (C) 2023 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (). Prior results do not guarantee a similar outcome with respect to any future matter.
律師廣告。(C) 2023 Monterverde & Associates負責這則廣告的律師事務所是 Monteverde & Associates PC ()。先前的結果並不能保證未來任何事項都會有類似的結果。
SOURCE Monteverde & Associates PC
SOURCE Monteverde
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧